Shivanand Kumatagi Reflects on His Visit to Rela Hospital
Shivanand Kumatagi, Development Officer (India) at ICCBBA, shared on LinkedIn:
”Productive Visit to Rela Hospital, Chennai
I had the opportunity to visit Rela Hospital, Chennai and it was a pleasure engaging with the Transfusion Medicine team on the importance of adopting ISBT128 standardized labeling for blood and cellular therapy products.
We discussed how the increasing use of advanced technologies—including automation, barcodes, and RFID—brings tremendous benefits but also introduces new challenges related to accuracy, interoperability, and traceability.
This is exactly where standardized, globally recognized ISBT128 play a crucial role.
They help overcome these obstacles by ensuring consistency, reducing errors, and enabling seamless communication across diverse platforms and systems.
It was encouraging to see the team’s positive response and their commitment to aligning with international standards and global best practices to enhance patient safety.
Looking forward to continuing this conversation and supporting the further strengthening of transfusion services.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests